These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


295 related items for PubMed ID: 12465458

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A diagnostic index of active demyelination: myelin basic protein in cerebrospinal fluid.
    Cohen SR, Brooks BR, Herndon RM, McKhann GM.
    Ann Neurol; 1980 Jul; 8(1):25-31. PubMed ID: 6157350
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Detection of myelin basic protein in cerebrospinal fluid and serum from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Ohta M, Ohta K, Nishimura M, Saida T.
    Ann Clin Biochem; 2002 Nov; 39(Pt 6):603-5. PubMed ID: 12564844
    [Abstract] [Full Text] [Related]

  • 7. Measurement of immunoreactive myelin basic protein peptide (45-89) in cerebrospinal fluid.
    Gupta MK, Whitaker JN, Johnson C, Goren H.
    Ann Neurol; 1988 Mar; 23(3):274-80. PubMed ID: 2454068
    [Abstract] [Full Text] [Related]

  • 8. Myelin basic protein in the CSF of patients with multiple sclerosis, optic neuritis and various neurological diseases.
    Pavarotti V, Merelli E, De Palma M, Bettelli G, Faglioni P.
    Acta Neurol Belg; 1986 Mar; 86(5):311-6. PubMed ID: 2433886
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis.
    Olsson T, Baig S, Höjeberg B, Link H.
    Ann Neurol; 1990 Feb; 27(2):132-6. PubMed ID: 1690527
    [Abstract] [Full Text] [Related]

  • 11. The relationship between levels of cerebrospinal fluid myelin basic protein and IgG measurements in patients with multiple sclerosis.
    Warren KG, Catz I.
    Ann Neurol; 1985 May; 17(5):475-80. PubMed ID: 2408558
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis.
    Adachi K, Kumamoto T, Araki S.
    Ann Neurol; 1990 Nov; 28(5):687-91. PubMed ID: 2260855
    [Abstract] [Full Text] [Related]

  • 14. Oligoclonal immunoglobulins and immunoreactive myelin basic protein in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.
    Cerri CG, Silani V, Scarlato G.
    Acta Neurol (Napoli); 1985 Nov; 7(3-4):311-4. PubMed ID: 2414977
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patients.
    Gallo P, Piccinno M, Pagni S, Tavolato B.
    Ann Neurol; 1988 Dec; 24(6):795-7. PubMed ID: 3264690
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.